Avecho Biotechnology (ASX:AVE) Dividend Yield %: 0.00% (As of Jul. 06, 2026)


What is Avecho Biotechnology Dividend Yield %?

Avecho Biotechnology ASX:AVE Dividend Yield % is 0.00% as of Jul. 06, 2026. The stock has 2 warning signs investors should review. Among 152 Biotechnology companies, Avecho Biotechnology ranks worse than 657894.08% on this metric.

As of today (2026-07-06), the Trailing Annual Dividend Yield of Avecho Biotechnology is 0.00%.

The historical rank and industry rank for Avecho Biotechnology's Dividend Yield % or its related term are showing as below:

ASX:AVE's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.355
* Ranked among companies with meaningful Dividend Yield % only.

Avecho Biotechnology's Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00.

As of today (2026-07-06), the Forward Dividend Yield % of Avecho Biotechnology is 0.00%.

Avecho Biotechnology's Dividends per Share for the six months ended in Dec. 2025 was A$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Avecho Biotechnology  (ASX:AVE) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Avecho Biotechnology Dividend Yield % Related Terms

Avecho Biotechnology Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Avecho Biotechnology's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avecho Biotechnology Dividend Yield % Chart

Avecho Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Avecho Biotechnology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:AVE vs VRTX, REGN, ALNY: Dividend Yield % Comparison

For the Biotechnology subindustry, Avecho Biotechnology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avecho Biotechnology Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Avecho Biotechnology's Dividend Yield % falls into.


Avecho Biotechnology Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Avecho Biotechnology (ASX:AVE) has a Dividend Yield % of 0.00% as of Jul. 06, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Avecho Biotechnology and its competitors. According to the industry distribution chart, Avecho Biotechnology ranks #999999 out of 152 companies in the Biotechnology industry.
Is Avecho Biotechnology's Dividend Yield % too high?
Avecho Biotechnology's current Dividend Yield % is 0.00%. Based on the distribution chart, Avecho Biotechnology ranks #999999 out of 152 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Avecho Biotechnology's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Avecho Biotechnology ranks #999999 out of 152 companies for Dividend Yield %. This places Avecho Biotechnology in the lower half of its industry. The industry median Dividend Yield % is 1.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.36, based on 152 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Avecho Biotechnology and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avecho Biotechnology's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (ASX:AVE) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Avecho Biotechnology (ASX:AVE), the current Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avecho Biotechnology Business Description

Other Exchanges OEZ:Germany
Address Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.